Follow
S2Medical AB
Nasdaq First North GM (Sweden)
S2Medical AB is a research intensive medtech company from Sweden. The company has developed several unique wound care products and have many disruptive technologies in the pipeline. Its products include wound debridment, blood stilling, skin grafting, tissue substitutes, bandage, and antimicrobial.
Sector:
HEALTH CARE
>
Medical Devices
Healthcare
Rights issue
Price
7.50 SEK
Subscription period
20 Nov - 04 Dec 2020
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
S2M
SE0011725084
Nasdaq First North GM
Sweden (SE)
Details of share in S2Medical AB with ticker S2M
Status
Active
Order book id
Amount of instruments
8 795 000
Par value
0.0600
Market cap
Currency
SEK
Segment
First North
First trading date
28 Nov 2018
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
14.50 SEK
87.52M SEK
05 Nov - 16 Nov 2018
IPO in S2Medical AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
7.50 SEK
84.8M SEK
20 Nov - 04 Dec 2020
Share issue in S2Medical AB
People
Number of Employees
12 people
Petter Sivlér
CEO
Martin Zetterström
Chairman of the board
Mårten Skog
Board member
Martin Zetterström
Board member
Carsten Browall
Board member
Roland Frösing
Board member
Amin Omrani
Board member
Company Details
Sector
HEALTH CARE
Website

Address
Sunnorpsgatan 5
Zip code
582 73
City/district
Linköping
Country
Sweden (SE)
Registration number
556934-8344
LEI code
549300K2RWH68WNUI509
First trade date
28 Nov 2018
Registration date
18 Jun 2013
Short name
S2Medical

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date